Deanna McLeod discusses the importance of the precautionary principle when considering therapeutic products during pregnancy and breastfeeding. She describes the shift from proving safety before authorization during these vulnerable periods. This is particularly concerning considering the COVID-19 genetic vaccines qualify as gene therapy.
